ClinicalTrials.Veeva

Menu

The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy

Unilever logo

Unilever

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: fruit extract
Dietary Supplement: no added fruit extract

Study type

Interventional

Funder types

Industry

Identifiers

NCT02388503
FDS-NAA-1946

Details and patient eligibility

About

This study is designed to identify the minimal effective tested dose of fruit extract consumed with a bread which provides a reduction in venous post-prandial blood glucose compared to a reference bread.

Enrollment

64 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2.
  • Apparently healthy males and females: no medical conditions which might affect the study measurements including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases.
  • Fasting blood glucose value of subjects ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening.

Exclusion criteria

  • Use of antibiotics within 3 months before day 1; use of any other medication except paracetamol, within 14 days before day 1.
  • Blood donation in the past 3 months and/or during the study.
  • Reported intense sporting activities > 10 h/week.
  • Consumption of > 14 units (female subjects) and > 21 units (male subjects) alcoholic drinks in a typical week.
  • Reported dietary habits: medically prescribed diet, slimming diet, not used to eat 3 meals a day, vegetarian.
  • If female, is pregnant (or has been pregnant during the last < 3 months) or will be planning pregnancy during the study period.
  • If female, is lactating or has been lactating in the 6 weeks before screening and/or during the study period.
  • Dislike, known allergy or intolerance to test products or other food products provided during the study.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

64 participants in 5 patient groups, including a placebo group

Reference
Placebo Comparator group
Description:
No added fruit extract
Treatment:
Dietary Supplement: no added fruit extract
Active 1
Active Comparator group
Description:
lowest dose of fruit extract
Treatment:
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Active 2
Active Comparator group
Description:
low dose of fruit extract
Treatment:
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Active 3
Active Comparator group
Description:
medium dose of fruit extract
Treatment:
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Active 4
Active Comparator group
Description:
high dose of fruit extract
Treatment:
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract
Dietary Supplement: fruit extract

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems